MoneyWorks4Me

The revenue zoomed 18.03% to Rs. 1681.83 millions for the quarter ended March 2025 as compared to Rs. 1424.93 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 115.74 millions from Rs. 185.97 millions, a decline of -37.76% on QoQ basis.The company reported a degrowth in operating Profit to 198.39 millions from 254.02 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1681.83 1424.93 18.03 6232.30 5805.50 7.35 6232.30 5805.50 7.35
Other Income -68.80 70.19 -198.02 224.77 344.22 -34.70 224.77 344.22 -34.70
PBIDT 198.39 254.02 -21.90 1239.71 1343.30 -7.71 1239.71 1343.30 -7.71
Interest 3.67 4.99 -26.45 18.83 14.63 28.71 18.83 14.63 28.71
PBDT 194.72 249.03 -21.81 1220.88 1328.67 -8.11 1220.88 1328.67 -8.11
Depreciation 32.26 26.86 20.10 128.99 106.25 21.40 128.99 106.25 21.40
PBT 162.46 222.17 -26.88 1091.89 1222.42 -10.68 1091.89 1222.42 -10.68
TAX 46.72 36.20 29.06 268.42 289.38 -7.24 268.42 289.38 -7.24
Deferred Tax -19.79 -4.93 301.42 15.15 34.95 -56.65 15.15 34.95 -56.65
PAT 115.74 185.97 -37.76 823.47 933.04 -11.74 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 11.80 17.83 -33.83 19.89 23.14 -14.03 19.89 23.14 -14.03
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..